Biosimilars: No big dollar savings, but are clinically ‘dead on’March 7, 2017Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisBusiness of Medicine
Humira Pen topped per-person drug spending in 2016February 28, 2017Rheumatoid ArthritisPsoriatic ArthritisBusiness of Medicine
Five quick ways HHS Secretary Tom Price could change the course of health policyFebruary 11, 2017Business of Medicine
